Navonil DS

(Pronouns He/Him). DAD/Husband/Scientist @ProstateCancer @CancerGenomics @Biomarker_Research @Mountain_Lover @DNA repair @Signature 'tweet are mine'

[Navonil DS @Navonilde]

Excited to release my lab's first preprint! A foundational model for clone & epistasis-aware biomarkers. This approach addresses key challenges in understanding genetic interactions & clonal dynamics.
Looking forward to feedback & new collaborations! https://t.co/BoQfBwJGkO

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

ATM rarely confers sensitivity to PARPi. But it does confer sensitivity to TOPO1 inhibitors. 👉🔥🎯
https://t.co/6mWTdj32oO

[Navonil DS @Navonilde]

So glad to be a part in this photo. Great updates.

[Prostate Cancer Foundation @PCFnews]

The world’s leading prostate cancer researchers came to Carlsbad to share their work, and patients and caregivers came with the questions that matter most.

For 33 years, PCF has brought science and lived experience together to move research forward.

#PCFRetreat26

[Prostate Cancer Foundation @PCFnews]

The world’s leading prostate cancer researchers came to Carlsbad to share their work, and patients and caregivers came with the questions that matter most.

For 33 years, PCF has brought science and lived experience together to move research forward.

#PCFRetreat26

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

Delighted that he is joining precision/rare/phase 1

[Navonil DS @Navonilde]

@HsiehLab Congratulations Andrew! You earned it. So happy to hear this news! Cheers!

[Navonil DS @Navonilde]

@Dr_R_Kurzrock :). Earth's gravity you mean? He he.

[Navonil DS @Navonilde]

@Sharmakomal_27 great collection of research. Enjoy reading!

[Cancer Discovery @CD_AACR]

The Tumor Microenvironment article collection explores recent advances characterizing the complex interactions and spatial associations between cell types in the TME and identifies potential pathways for improved cancer therapies directed against the TME. https://t.co/z70qWEuwEI

[Dr. Bishoy M. Faltas @FaltasLab]

I’m excited to launch Science in GU Oncology, a new monthly newsletter in partnership with @urotoday Each issue will cover the latest scientific advances in GU cancers and what they mean for patient care. https://t.co/wGtPvjZQdJ

[Prostate Cancer Foundation @PCFnews]

One diagnosis sparked a movement. 💙

After being diagnosed with advanced prostate cancer, Michael Milken founded the Prostate Cancer Foundation. His mission: accelerate research and improve outcomes for patients everywhere. More than 30 years later, that mission remains true.

[Dr. Thomas Ichim @exosome]

Finally !! a CAR-T that works on solid tumors.

Nature paper… 32 out of 36 patients had regression of advanced #cancer.

Target rglypican and tgf beta.

@IntegrativeCCA $IBRX #anktiva will enhance

https://t.co/Z9oPHIc37p

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

The Center for Precision Oncology and Rare Cancers/Precision Medicine and Rare Cancer Clinic at MCW could not function without our pharmacists
https://t.co/74ujgv98kQ

[Navonil DS @Navonilde]

@nidhan

[Cancer Discovery @CD_AACR]

Now online: Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T Cells in KRAS -Mutant Cholangiocarcinoma https://t.co/f8Y8Uvw5c6

[Cancer Discovery @CD_AACR]

Now online: Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T Cells in KRAS -Mutant Cholangiocarcinoma https://t.co/f8Y8Uvw5c6

[Navonil DS @Navonilde]

@UrologySBUR @Sharmakomal_27

[Cancer Discovery @CD_AACR]

Now online: Germline CDK12 variants in aggressive prostate cancer https://t.co/ICOQP46UIm

[Navonil DS @Navonilde]

@Ecastromarcos Congratulations team.

[Vivek Subbiah, MD @VivekSubbiah]

FDA approves Orca Bio’s T cell therapy for blood cancer patients https://t.co/MdAlBcwOv1 via @statnews

[Medical College of Wisconsin @MedicalCollege]

Hope changes everything.

At its heart, the Michels’ $27 million gift to MCW’s Center for Cancer Discovery is about the families facing a cancer diagnosis today—and those who will face one tomorrow. By investing in groundbreaking research, Tim and Barbara Michels are helping bring new hope, new possibilities, and new pathways to better outcomes for patients everywhere.

[Navonil DS @Navonilde]

Can't agree more.

[Prostate Cancer Foundation @PCFnews]

PCF Young Investigator Awards recognize early career scientists poised to lead the future of prostate cancer research.

Andrea Miyahira, Ph.D., PCF VP of Global Research & Innovation, shares how these awards help accelerate promising research careers.

[nature @Nature]

Obituary: J Craig Venter (1946-2026) maverick biotechnologist who sequenced the human genome

https://t.co/da4g7Aeni5